Literature DB >> 22398853

Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw.

J Narváez, J A Narváez, C Gómez-Vaquero, J M Nolla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22398853     DOI： 10.1007/s00198-012-1918-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  8 in total

1.  Teriparatide therapy for alendronate-associated osteonecrosis of the jaw.

Authors:  Ada Cheung; Ego Seeman
Journal:  N Engl J Med       Date:  2010-10-16       Impact factor: 91.245

2.  Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)].

Authors:  Richard P Harper; Eugene Fung
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

3.  Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy.

Authors:  Arthur N Lau; Jonathan D Adachi
Journal:  J Rheumatol       Date:  2009-08       Impact factor: 4.666

4.  More on the resolution of bisphosphonate-associated osteonecrosis of the jaw.

Authors:  Kuo-Yang Tsai; Chin-Sheng Huang; Guan-Min Huang; Chen-Tung Yu
Journal:  J Rheumatol       Date:  2010-03       Impact factor: 4.666

Review 5.  A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution.

Authors:  Gayathri Subramanian; Harold V Cohen; Samuel Y P Quek
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-08-06

Review 6.  Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report.

Authors:  Pongthorn Narongroeknawin; Maria I Danila; Lewis G Humphreys; Andrei Barasch; Jeffrey R Curtis
Journal:  Spec Care Dentist       Date:  2010 Mar-Apr

7.  Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy.

Authors:  Jang-Jaer Lee; Shih-Jung Cheng; Jiiang-Huei Jeng; Chun-Pin Chiang; Hon-Ping Lau; Sang-Heng Kok
Journal:  Head Neck       Date:  2010-03-22       Impact factor: 3.147

Review 8.  Effects of parathyroid hormone on immune function.

Authors:  Abdallah Sassine Geara; Mario R Castellanos; Claude Bassil; Georgia Schuller-Levis; Eunkue Park; Marianne Smith; Michael Goldman; Suzanne Elsayegh
Journal:  Clin Dev Immunol       Date:  2010-09-16
  8 in total
  4 in total

1.  Comment on Narváez et al.: lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw.

Authors:  G Subramanian; S Y P Quek
Journal:  Osteoporos Int       Date:  2012-05-12       Impact factor: 4.507

2.  Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw: reply to Subramanian and Quek.

Authors:  J Narváez
Journal:  Osteoporos Int       Date:  2012-05-12       Impact factor: 4.507

3.  Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: a pilot study comparing fibrin rich in growth factors and teriparatide.

Authors:  Alejandro Pelaz; Luis Junquera; Lorena Gallego; Luis García-Consuegra; Sonsoles Junquera; Carlos Gómez
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-07-01

Review 4.  Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ).

Authors:  Yong-Dae Kwon; Deog-Yoon Kim
Journal:  Dent J (Basel)       Date:  2016-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.